SCHEDULE: Vanguard Reports Zero GoodRx Holdings Post-Realignment

The Vanguard Group has reported 0% beneficial ownership in GoodRx Holdings Inc. following an internal realignment.

Summary

• The Vanguard Group reported 0% beneficial ownership of GoodRx Holdings Inc. Common Stock.
• This change is a result of an internal realignment within The Vanguard Group, Inc. that occurred on January 12, 2026.
• Following the realignment, certain subsidiaries or business divisions of Vanguard will now report their beneficial ownership separately.
• The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by these subsidiaries and/or business divisions.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of GoodRx Holdings Inc.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral. It primarily reflects an internal organizational and reporting change by The Vanguard Group, not a direct positive or negative assessment of GoodRx Holdings Inc.'s performance or prospects.

Future Outlook

The filing does not provide any forward-looking statements or guidance regarding GoodRx Holdings Inc.'s operational or financial performance. It primarily details a change in The Vanguard Group's reporting structure for beneficial ownership.

Management Comments

• "On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release."
• "The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions."

Industry Context

StockSavvy.ai notes that internal realignments and subsequent changes in beneficial ownership reporting are standard practices for large institutional investors like The Vanguard Group. This filing reflects a structural change in how Vanguard's various entities report their holdings rather than a direct investment decision regarding GoodRx Holdings Inc. by the entire Vanguard ecosystem.

Stakeholder Impact

• Shareholders of GoodRx Holdings Inc. may see a change in the reported institutional ownership figures from The Vanguard Group, as holdings will now be disaggregated among its subsidiaries.
• Investment professionals tracking institutional ownership will need to consider the combined holdings of Vanguard's various entities for a complete picture of its overall exposure to GoodRx.

Next Steps

• Certain subsidiaries or business divisions of The Vanguard Group, Inc. will report their beneficial ownership of GoodRx Holdings Inc. separately on a disaggregated basis.

Key Dates

Keywords

GoodRx Holdings Inc, Vanguard Group, Schedule 13G, Beneficial Ownership, Institutional Ownership, Reporting Change, Common Stock